tamoxifen
Not Tagged
['ovarian', 'tamoxi']
at #asco23 single patient meta-analysis by #ebctcg of 14,999 pts from 23 trials on ovarian suppression: ovarian suppression was associated with reduced risk of recurrence and mortality benefit seems larger for women who received no tamoxifen vs those who did 
MD, Medical Oncologist🇮🇹•Research Fellow at @JulesBordet Institute in Brussels🇧🇪 Great interest in #BreastCancer and #ImmunoOncology